National Case Conference - January 2024

Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Continue

Cases with Topics including Alcohols & Glycols and Neurology

Case 1: A 63-year-old man presents with loss of vision and 'fixed dilated pupils.' He is noted to have profound acidemia with elevated lactate, AKI, and hyperammonemia. He is given fomepizole and is hemodialyzed.

Case 2: A 62-year-old man presents to the ED after ingesting diltiazem, acetaminophen, aspirin, bupropion, and amitriptyline in a suicide attempt. While in the ICU he becomes hyperthermic to 107F.

Case 3: A 25-year-old man presents to the ED after he was found seizing in his car. On arrival he is agitated, has a seizure, and is intubated.

Today's Moderator: Joshua D. King, MD, FACMT, Associate Professor, Medicine and Pharmacy; Medical Director, University of Maryland School of Medicine & University of Maryland School of Medicine, Baltimore MD

Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

This webinar is for ACMT members only.

Joshua D. King, MD, FACMT

Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center

University of Maryland School of Medicine

Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.